Analysis of tumor necrosis factor-α promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese

Tissue Antigens

Volumn 55, Issue 1, 2000, Pages 10-16

  Hamaguchi, Kazuyuki ^a   Kimura, A ^c   Seki, N ^c   Higuchi, T ^c   Yasunaga, S ^b   Takahashi, M ^c   Sasazuki, T ^b   Kusuda, Y ^a   Okeda, T ^a   Itoh, K ^c   Sakata, T ^a  

^a OITA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NONE

Author keywords

DNA typing; HLA; Japanese; Linkage disequilibrium; Polymorphism; Promoter region; TNF a; Type 1 diabetes

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HUMAN; HUMAN TISSUE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; NEWBORN; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; RISK;

ADOLESCENT; ADULT; ALLELES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033979837     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.550102.x     Document Type: Article

References (38)

1. 1. Aggarwal BB, Puri RK, eds. Human cytokines: their role in disease and therapy. Cambridge: Blackwell Science, 1995.
2. 2. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998: 55: 1139-49.
3. 3. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha OH. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci U S A 1990: 87: 968-72.
4. 4. Todd JA. The role of MHC class II genes in susceptibility to insulin-dependent diabetes mellitus. In: Baeckkeskov S, ed. Current Topics in Microbiology and Immunology. Berlin: Springer-Verlag, 1990: 17-40.
5. 5. Sheehy MJ, Scharf SJ, Rowe JR et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989: 83: 830-5.
6. 6. Erlich HA. HLA class II polymorphism and genetic susceptibility to insulin-dependent diabetes mellitus. Curr Top Microbiol Immunol 1990: 164: 41-55.
7. 7. Yamagata K, Hanafusa T, Nakajima H et al. HLA-DQA1*1 contributes to resistance and A1*3 confers susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1991: 34: 133-6.
8. 8. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y. Genetic analysis of HLA class II alleles and susceptibility to Type I (insulin-dependent) diabetes mellitus in Japanese subjects, Diabetologia 1992: 35: 419-24.
9. 9. Hamaguchi K, Kimura A, Dong RP et al. Specific combinations of HLA-DRB and -DQB alleles confer susceptibility while the DQB gene determines resistance to insulin-dependent diabetes mellitus in Japanese. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Vol II. Oxford: Oxford University Press, 1992: 488-92.
10. 10. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type I (insulin-dependent) diabetes mellitus. Diabetologia 1993: 36: 371-7.
11. 11. Kobayashi T, Tamemoto K, Nakanishi K et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 1993: 16: 780-8.
12. 12. Fennessy M, Metcalfe K, Hitman GA et al. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood diabetes in Finland (DiMe) Study Group. Diabetologia 1994: 37: 937-44.
13. 13. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor-α (TNF-α) -308 promoter polymorphism in TNF-α gene regulation. J Inflamm 1995-96: 46: 32-41.
14. 14. Whichelow CE, Hitman GA, Raafat I, Bottazzo GF, Sachs JA. The effect of TNF*B gene polymorphism on TNF-α and -β secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. Eur J Immunogenet 1996: 23: 425-35.
15. 15. Pociot F, Wilson AG, Nerup J, Duff GW. No independent association between a tumor necrosis factor-α promotor region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 1993: 23: 3050-3.
16. 16. Cox A, Gonzalez AM, Wilson AG et al. Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor-α with human IDDM. Diabetologia 1994: 37: 500-3.
17. 17. Deng GY, Maclaren NK, Huang HS, Zhang LP, She JX. No primary association between the 308 polymorphism in the tumor necrosis factor-α promoter region and insulin-dependent diabetes mellitus. Hum Immunol 1996: 45: 137-42.
18. 18. Monos DS, Kamoun M, Udalova IA et al. Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus. Linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes. Hum Immunol 1995: 44: 70-9.
19. 19. Hamada Y, Ikegami H, Yamato E et al. Polymorphism of TNFB gene is associated with specific HLA alleles, but not with insulin-dependent diabetes mellitus in Japanese population. Diabetes Res 1996: 31: 171-9.
20. 20. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998: 51: 605-12.
21. 21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997: 20: 1183-97.
22. 22. Terasaki PI. Cytotoxicity technique. In: Brand DR, Ray JG, eds. Manual of tissue typing techniques. Bethesda: National Institutes of Health, 1970: 42-5.
23. 23. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Vol. I. Oxford: Oxford University Press, 1992: 397-419.
24. 24. Kimura A, Dong RP, Harada H, Sasazuki T. DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens 1992: 40: 5-12.
25. 25. Bunce M, Fanning GL, Welsh KI. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens 1995: 45: 81-90.
26. 26. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994: 43: 18-27.
27. 27. Uglialoro AM, Turbay D, Pesavento PA et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens 1998: 52: 359-67.
28. 28. Kida K, Mimura G, Kobayashi T et al. Immunogenetic heterogeneiety in Type I (insulin-dependent) diabetes among Japanese-HLA antigens and organ-specific autoantibodies. Diabetologia 1989: 32: 34-9.
29. 29. Mimura G, Kida K, Matsuura N et al. Immunogenetics of early-onset insulin-dependent diabetes mellitus among the Japanese: HLA, Gm, BF, GLO, and organspecific autoantibodies - the J.D.S. study. Diabetes Res Clin Pract 1990: 8: 253-6 2.
30. 30. Bozon MV, Delgado JC, Selvakuman A et al. Error rate for HLA-B antigen assignment by serology: implications for proficiency testing and utilization of DNA-based typing methods. Tissue Antigens 1997: 50: 387-9 4.
31. 31. Nakanishi K, Kobayashi T, Murase T et al. Association of HLA-A24 with complete β-cell destruction in IDDM. Diabetes 1993: 42: 1086-9 3.
32. 32. Mizota M, Uchigata Y, Moriyama S et al. Age-dependent association of HLA-A24 in Japanese IDDM patients. Diabetologia 1996: 39: 371-3.
33. 33. Awata T, Izumida T, Kikuchi C, Katayama S. Response from the authors. Diabetologia 1996: 39: 373.
34. 34. Mimori A, Takeuchi F, Tokunaga K et al. Restriction fragment length polymorphism of complement C4 in Japanese patients with rheumatoid arthritis and normal Japanese. Tissue Antigens 1990: 35: 197-202.
35. 35. Kobayashi K, Atoh M, Hara M et al. Association between restriction fragment length polymorphisms detected with a probe for human C4 and allotype of C4B5 allele. Hum Immunol 1990: 29: 3-13.
36. 36. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Estimation of allele and haplotype frequencies for HLA and complement loci. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Vol. 1. Oxford: Oxford University Press, 1992: 76-9.
37. 37. Honda K, Kimura A, Dong RP et al. Immunogenetic analysis of silicosis in Japan. Am J Resp Cell Mol Biol 1993: 8: 106-11.
38. 38. Tsuchiya K, Kondo M, Kimura A, Nishimura Y, Sasazuki T. The HLA-DRB1 and/or the DQB1 locus controls susceptibility and the DRB1 locus controls resistance to rheumatoid arthritis in the Japanese. In: Sasazuki T, Aizawa M, Tsuji K, eds. HLA 1991. Vol. 2. Oxford: Oxford University Press, 1992: 509-12.